Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
BEAT

BEAT - BioTelemetry Inc Stock Price, Fair Value and News

2.00USD+0.03 (+1.52%)Market Closed

Market Summary

BEAT
USD2.00+0.03
Market Closed
1.52%

BEAT Stock Price

View Fullscreen

BEAT RSI Chart

BEAT Valuation

Market Cap

52.7M

Price/Earnings (Trailing)

-3.6

EV/EBITDA

-2.49

Price/Free Cashflow

-4.26

MarketCap/EBT

-3.6

BEAT Price/Sales (Trailing)

BEAT Profitability

Return on Equity

-91.86%

Return on Assets

-85.45%

Free Cashflow Yield

-23.45%

BEAT Fundamentals

BEAT Earnings

Earnings (TTM)

-14.6M

Earnings Growth (Yr)

-4.5%

Earnings Growth (Qtr)

-11.79%

Breaking Down BEAT Revenue

Last 7 days

3.6%

Last 30 days

-9.9%

Last 90 days

7.5%

Trailing 12 Months

-1.0%

How does BEAT drawdown profile look like?

BEAT Financial Health

BEAT Investor Care

Shares Dilution (1Y)

220.03%

Diluted EPS (TTM)

-0.82

Tracking the Latest Insider Buys and Sells of BioTelemetry Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Sep 29, 2023
de urioste george
sold
-11,330
2.06
-5,500
-
Sep 28, 2023
de urioste george
sold
-16,320
2.04
-8,000
-
Sep 27, 2023
de urioste george
sold
-3,869
2.11
-1,834
-
Sep 26, 2023
de urioste george
sold
-10,450
2.09
-5,000
-
Sep 22, 2023
de urioste george
sold
-5,288
2.21
-2,393
-
Sep 21, 2023
de urioste george
sold
-241
2.41
-100
-
Sep 20, 2023
de urioste george
sold
-2,172
2.46
-883
-
Sep 18, 2023
de urioste george
sold
-12,300
2.46
-5,000
-
Sep 15, 2023
de urioste george
sold
-10,373
2.43
-4,269
-
Sep 14, 2023
de urioste george
sold
-10,850
2.17
-5,000
-

1–10 of 47

Which funds bought or sold BEAT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 25, 2024
Bank of New York Mellon Corp
sold off
-100
-42,864
-
 -%
Apr 23, 2024
Spectrum Asset Management, Inc. (NB/CA)
unchanged
-
-7,633
97,882
 0.04%
Apr 16, 2024
Pasadena Private Wealth, LLC
reduced
-0.93
-15,856
179,979
 0.04%
Mar 11, 2024
VANGUARD GROUP INC
added
69.97
543,089
1,176,230
 -%
Feb 26, 2024
Virtu Financial LLC
new
-
333,000
333,000
 0.03%
Feb 16, 2024
HARBOUR INVESTMENTS, INC.
unchanged
-
3,950
46,413
 -%
Feb 15, 2024
Baker Avenue Asset Management, LP
reduced
-30.00
-33,666
109,670
 -%
Feb 14, 2024
CLEAR STREET LLC
reduced
-5.61
1,000
1,000
 -%
Feb 14, 2024
FIRST FOUNDATION ADVISORS
new
-
23,500
23,500
 -%
Feb 14, 2024
AE Wealth Management LLC
unchanged
-
-3,765
24,148
 -%

1–10 of 43

Are Funds Buying or Selling BEAT?

Are funds buying BEAT calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own BEAT
No. of Funds

Unveiling BioTelemetry Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Oct 25, 2023
strome mark e
12.0%
3,150,000
SC 13D
Aug 28, 2023
public ventures, llc
9.41%
2,624,910
SC 13D
Jun 02, 2023
schwartzberg andrew
7.33%
1,899,536
SC 13D
Feb 13, 2023
ionic ventures, llc
0.52%
41,519
SC 13G/A
Jan 10, 2023
sabby management, llc
3.40%
271,788
SC 13G/A
Feb 03, 2022
ionic ventures, llc
9.99%
813,522
SC 13G/A
Mar 10, 2021
arrowmark colorado holdings llc
0.0%
0
SC 13G/A
Feb 16, 2021
arrowmark colorado holdings llc
11.4%
3,927,595
SC 13G/A
Feb 10, 2021
vanguard group inc
10.16%
3,486,540
SC 13G/A
Jan 25, 2021
blackrock inc.
15.6%
5,368,860
SC 13G

Recent SEC filings of BioTelemetry Inc

View All Filings
Date Filed Form Type Document
Apr 19, 2024
PRE 14A
PRE 14A
Mar 20, 2024
10-K
Annual Report
Feb 05, 2024
8-K
Current Report

Peers (Alternatives to BioTelemetry Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
UNH
456.6B
371.6B
 0.44% 0.97%
20.4
1.23
 14.64% 11.24%
CI
103.6B
195.3B
 -2.45% 41.59%
19.29
0.53
 8.17% -20.79%
CVS
84.5B
357.8B
 -15.42% -8.05%
10.12
0.24
 10.95% 93.52%
HCA
81.1B
65.0B
 -7.58% 8.53%
15.47
1.25
 7.86% -7.11%
CNC
39.7B
155.5B
 -5.58% 8.00%
14.51
0.26
 6.34% 84.42%
DVA
11.7B
12.1B
 -2.44% 51.70%
16.93
0.96
 4.57% 23.40%
UHS
11.5B
14.3B
 -8.81% 13.72%
16.01
0.8
 6.59% 6.24%
MID-CAP
CHE
8.5B
2.3B
 -13.21% 2.71%
31.02
3.73
 6.06% 9.17%
ACHC
6.8B
2.9B
 -6.00% 1.13%
-313.66
2.32
 12.20% -107.93%
AMN
2.2B
3.8B
 -7.09% -33.84%
10.27
0.57
 -27.73% -52.50%
AMEH
2.0B
1.4B
 -10.80% 1.66%
33.48
1.47
 21.19% 34.42%
SMALL-CAP
ADUS
1.5B
1.1B
 -8.94% -17.15%
24.52
1.45
 11.31% 35.83%
BKD
1.3B
3.0B
 5.61% 63.76%
-6.97
0.44
 6.74% 20.73%
BEAT
52.7M
-
 -9.91% -0.99%
-3.6
-
 - -12.94%
AMS
20.1M
21.3M
 17.84% 15.27%
37.65
0.94
 8.00% -62.25%

BioTelemetry Inc News

Latest updates
Philips • 3 years ago
Philips completes acquisition BioTelemetry - News
Marketscreener.com • 3 years ago
Philips Holding USA Inc. completed the acquisition of BioTelemetry, Inc..
The Motley Fool • 5 years ago
Why BioTelemetry Stock Plunged Today
Philadelphia Business Journal • 5 years ago
BioTelemetry agrees to buy California-based medical device company for $65M - Philadelphia Business Journal
InvestorPlace • 5 years ago
10 Small-Caps Leading the Market Rebound
TradingView • 6 years ago
BEAT Stock Price and Chart — NASDAQ:BEAT — TradingView
Yahoo Movies UK • 6 years ago
BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher
Yahoo Finance • 6 years ago
BioTelemetry (BEAT) Acquires LifeWatch for $280 Million
Yahoo Canada Shine On • 9 years ago
Strength Seen in Covance (CVD): Stock Surges 25.9%

BioTelemetry Inc Earnings Report: Key Takeaways & Analysis

Balance Sheet
(In Thousands)
Balance Sheet
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32022Q42022Q32022Q22022Q12021Q42021Q32020Q4
Assets-12.8%17,13119,6484,0396,6729,73812,74113,998961-
  Current Assets-13.6%16,82519,4794,039------
    Cash Equivalents-15.6%16,18919,1843,5946,5499,27411,20113,19279524.00
  Net PPE77.8%256144-------
Liabilities17.2%1,1941,0191,6659327705145886,1484,836
Shareholder's Equity-14.5%15,93718,6292,3745,7408,96812,22713,410--
  Retained Earnings-11.8%-36,825-32,946-22,186-18,474-14,895-11,370-9,224-7,139-4,796
  Additional Paid-In Capital2.3%52,75951,57224,55924,21323,86223,59622,6331,95211.00
Shares Outstanding0.0%26,32926,3258,0108,1478,1468,0827,8103,7063,528
Float-----6,424----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q3
Cashflow From Operations-36.2%-2,858-2,098-4,023-3,114-2,955-2,725-1,929-2,339-2,441-365-269-155--
  Share Based Compensation28.2%1,18792670239334635126415910753.0023.009.00--
Cashflow From Investing-103.0%-1123,795------------
Cashflow From Financing-100.0%-11124,373510--2.0034814,838695650215--

BEAT Income Statement

2023-12-31
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating Expenses:  
General and administrative$ 8,516,000$ 7,354,000
Research and development6,798,0005,677,000
Total operating expenses15,314,00013,031,000
Loss from operations(15,314,000)(13,031,000)
Other income  
Interest income675,00066,000
Other income03,000
Total other income675,00069,000
Loss before provision for income taxes(14,639,000)(12,962,000)
Income tax provision00
Net Loss$ (14,639,000)$ (12,962,000)
Net loss per share, basic (in dollars per share)$ (0.72)$ (1.59)
Net loss per share, diluted (in dollars per share)$ (0.72)$ (1.59)
Weighted average common shares outstanding, basic (in shares)20,333,2808,168,516
Weighted average common shares outstanding, diluted (in shares)20,333,2808,168,516

BEAT Balance Sheet

2023-12-31
Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:  
Cash and cash equivalents$ 16,189$ 3,594
Prepaid expenses and other current assets636445
Total Current Assets16,8254,039
Property and equipment, net2560
Other assets500
Total Assets17,1314,039
Current Liabilities:  
Accounts payable and accrued expenses (includes related party $2 and $2, respectively)1,1941,665
Total Liabilities1,1941,665
Commitments (Note 7)
Stockholders’ Equity  
Preferred Stock - $0.0001 par value; 10,000,000 shares authorized; 0 shares outstanding at December 31, 2023 and 202200
Common stock - $0.0001 par value; 100,000,000 shares authorized; 26,329,032 and 8,009,743 shares issued and outstanding at December 31, 2023 and 202231
Additional paid in capital52,75924,559
Accumulated deficit(36,825)(22,186)
Total Stockholders’ Equity15,9372,374
Total Liabilities and Stockholders’ Equity$ 17,131$ 4,039

About BioTelemetry Inc

BEAT
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
 CEO
 WEBSITEheartbeam.com
 INDUSTRYHealthcare Plans
 EMPLOYEES10

BioTelemetry Inc Frequently Asked Questions

What is the ticker symbol for BioTelemetry Inc? What does BEAT stand for in stocks?

BEAT is the stock ticker symbol of BioTelemetry Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of BioTelemetry Inc (BEAT)?

As of Fri Apr 26 2024, market cap of BioTelemetry Inc is 52.66 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BEAT stock?

You can check BEAT's fair value in chart for subscribers.

What is the fair value of BEAT stock?

You can check BEAT's fair value in chart for subscribers. The fair value of BioTelemetry Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of BioTelemetry Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BEAT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is BioTelemetry Inc a good stock to buy?

The fair value guage provides a quick view whether BEAT is over valued or under valued. Whether BioTelemetry Inc is cheap or expensive depends on the assumptions which impact BioTelemetry Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BEAT.